$9.5 Million Settlement in Menlo Therapeutics Securities Litigation Granted Final Approval

A California state court has granted final approval to a $9.5 million settlement in a class action against Menlo Therapeutics, Inc. and certain of its officers, directors, and underwriters for alleged violations of Sections 11, 12(a)(2), and 15 the Securities Act of 1933.